1. Home
  2. PRPO vs FLGC Comparison

PRPO vs FLGC Comparison

Compare PRPO & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • FLGC
  • Stock Information
  • Founded
  • PRPO N/A
  • FLGC 2019
  • Country
  • PRPO United States
  • FLGC United States
  • Employees
  • PRPO N/A
  • FLGC N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • FLGC Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPO Industrials
  • FLGC Health Care
  • Exchange
  • PRPO Nasdaq
  • FLGC Nasdaq
  • Market Cap
  • PRPO 17.1M
  • FLGC 15.9M
  • IPO Year
  • PRPO N/A
  • FLGC 2021
  • Fundamental
  • Price
  • PRPO $14.45
  • FLGC $0.66
  • Analyst Decision
  • PRPO
  • FLGC Buy
  • Analyst Count
  • PRPO 0
  • FLGC 2
  • Target Price
  • PRPO N/A
  • FLGC $4.00
  • AVG Volume (30 Days)
  • PRPO 17.7K
  • FLGC 99.9K
  • Earning Date
  • PRPO 08-12-2025
  • FLGC 08-11-2025
  • Dividend Yield
  • PRPO N/A
  • FLGC N/A
  • EPS Growth
  • PRPO N/A
  • FLGC N/A
  • EPS
  • PRPO N/A
  • FLGC N/A
  • Revenue
  • PRPO $20,029,000.00
  • FLGC $53,260,000.00
  • Revenue This Year
  • PRPO N/A
  • FLGC N/A
  • Revenue Next Year
  • PRPO N/A
  • FLGC N/A
  • P/E Ratio
  • PRPO N/A
  • FLGC N/A
  • Revenue Growth
  • PRPO 26.67
  • FLGC N/A
  • 52 Week Low
  • PRPO $3.90
  • FLGC $0.42
  • 52 Week High
  • PRPO $16.89
  • FLGC $2.11
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 68.17
  • FLGC 51.57
  • Support Level
  • PRPO $14.25
  • FLGC $0.62
  • Resistance Level
  • PRPO $16.89
  • FLGC $0.72
  • Average True Range (ATR)
  • PRPO 1.08
  • FLGC 0.05
  • MACD
  • PRPO 0.24
  • FLGC 0.01
  • Stochastic Oscillator
  • PRPO 67.57
  • FLGC 58.56

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About FLGC Flora Growth Corp.

Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.

Share on Social Networks: